Exelixis | EXEL - Los Ingresos Por Intereses





Los Ingresos Por Intereses Cambio Fecha
Acadia Pharmaceuticals USD 7.99M 65K 2026-06
Agios Pharmaceuticals USD 9.73M 1.06M 2026-06
AstraZeneca USD 80M 7M 2026-06
Bayer EUR 169M 39M 2025-12
BioMarin Pharmaceutical USD 10.48M 12.08M 2026-06
Cytokinetics USD 13.94M 2.92M 2026-06
Eisai JPY 3.11B 783M 2024-03
Eli Lilly USD 65M 25M 2025-09
Exelixis USD 14.32M 105K 2026-09
Genmab DKK 14M 11M 2026-03
Glaxosmithkline GBP 29M 7M 2026-09
Incyte USD 38.12M 4.43M 2026-06
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
MacroGenics USD 1.37M 186K 2026-06
Merck USD 35M 0 2026-06
Moderna USD 72M 2M 2026-03
Nektar Therapeutics USD -0.18 0.07 2024-09
Pfizer USD 0.56 0.6 2026-09
Puma Biotechnology USD 0.41 0.5 2024-09
Sanofi EUR 77M 17M 2026-06
Takeda JPY 14.57B 10.04B 2026-09
Ultragenyx Pharmaceutical USD 5M 1000K 2026-06
Xencor USD 4.8M 659K 2026-06